RxDoctor Payments Data

Ashlie Bondarenko

Family · Burnsville, MNNPI 1326338773

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 41.9% of the total. Reporting peaked in 2023 at $3,243 and has fallen 79.7% since, to $660 in 2025. Among family clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,287in general payments, 2019–2025

Across 94 payments — averaging $66.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Boston Scientific$2K
  • Abbott$788
  • SPR Therapeutics, Inc$415
  • Nevro Corp.$254
  • Spinal Simplicity, LLC$96
  • plus $183 from 5 others

What the payments were for

  • Consulting fees$3005%
  • Travel & lodging$2,27936%
  • Food & beverage$3,65458%
  • Education$541%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,287 in reported general payments places this provider in the 95th percentile of 1,121 family providers in Minnesota.

See all family providers in Minnesota

Medicare billing

Part B allowed, 2024
$78,511
Medicare patients
177
Services billed
873

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine71$21,394
BelbucaBuprenorphine Hcl29$18,583
OxycontinOxycodone Hcl23$8,830
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen211$6,827
Oxycodone Hcl298$5,460
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen238$5,104
Xtampza ErOxycodone Myristate13$4,264
Pregabalin66$2,566
Fentanyl17$2,068
Tramadol Hcl ErTramadol Hcl26$2,017
Gabapentin114$1,954
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl14$1,878
Morphine Sulfate26$1,776
Hydromorphone Hcl78$1,476
Tramadol Hcl129$1,416

Paid to pharmacies, not to this prescriber.

Other family in Burnsville

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →